Prostate Cancer Clinical Trial
Official title:
A Randomised Trial Comparing The Bladder Volume Consistency Achieved With Two Bladder-Filling Protocols in Prostate Conformal Radiotherapy
RATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to
the tumor may kill more tumor cells and cause less damage to normal tissue. Having a full
bladder may improve the effectiveness of radiation therapy to the bladder. It is not yet
known which set of bladder-filling instructions is more effective in helping patients keep
their bladder full during radiation therapy.
PURPOSE: This randomized clinical trial is comparing two sets of bladder-filling
instructions in treating patients with prostate cancer undergoing radiation therapy.
OBJECTIVES:
Primary
- To compare the consistency in bladder volumes in patients with prostate cancer
undergoing conformal radiotherapy, when randomized to one of two sets of
bladder-filling instructions.
Secondary
- To compare the incidence of acute and late genitourinary and gastrointestinal toxicity
in patients treated with these methods.
- To determine patient satisfaction with the bladder-filling instructions.
- To determine satisfaction of bladder-filling protocols amongst radiation therapists and
doctors.
OUTLINE: Patients are randomized to 1 of 2 treatment arms.
- Arm I: Patients empty their bladders and consume 6 cups of water 30 minutes before
undergoing radiotherapy. Patients also undergo bladder volume measurements using a
bladder volume instrument (BVI) periodically during treatment.
- Arm II: Patients empty their bladders and consume 3 cups of water 30 minutes before
undergoing radiotherapy. Patients also undergo bladder volume measurements using a BVI
periodically during treatment.
In both arms, patients follow their bladder filling instructions and then undergo conformal
radiation therapy daily for about 8 weeks.
Patients' perception of symptoms, quality of life, and urinary symptoms are assessed
periodically by the International Prostate Symptom Score (I-PSS). Patients' satisfaction
with the bladder-filling instructions (i.e., ability to comply with the bladder-filling
protocol, the number of incidents of wetting accidents, number of incidents of having to
repeat the water drinking on the same day due to machine breakdown or the patient's
inability to retain the full bladder for the required amount of time, and the level of
frustration) is assessed periodically by the Visual Analogue Scale (VAS).
Staff satisfaction with bladder-filling interventions (i.e., patient compliance with the
protocols, acceptance of bladder dose-volume histograms [DVHs], need for re-scan with a
fuller bladder, amount of disruption to the therapist's work schedule, number of incidents
of wetting accidents, number of incidents of having to repeat the water drinking on the same
day due to machine breakdown or the patient's inability to retain the full bladder for the
required amount of time, and the level of satisfaction or frustration) is assessed
periodically.
After completion of study treatment, patients are followed up periodically for 4 years.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
| Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
| Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
| Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
| Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
| Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
| Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
| Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
| Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
| Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
| Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
| Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
| Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
| Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
| Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |